[Characteristics and prognosis of patients with primary sclerosing cholangitis].

原发性硬化性胆管炎 医学 小学(天文学) 内科学 胃肠病学 疾病 物理 天文
作者
Chen Shao,T T Meng,Wei Duan,Xue Li,T T Lyu,Yan Wang,Jidong Jia,Yuanyuan Kong,Hong You
出处
期刊:PubMed [National Institutes of Health]
卷期号:64 (3): 206-211
标识
DOI:10.3760/cma.j.cn112138-20241008-00663
摘要

Objective: Primary sclerosing cholangitis (PSC) is a rare autoimmune disease. This study aims to describe the baseline characteristics and clinical outcomes of Chinese PSC patients and explore risk factors associated with prognosis, addressing the lack of long-term prognostic analysis in China. Methods: Clinical data of PSC patients were retrospectively collected from May 2009 to June 2023 in Beijing Friendship Hospital Affiliated to Capital Medical University, and patient follow-up was conducted through outpatient visits, telephone calls, and medical record reviews. The Cox proportional hazards model and the Kaplan-Meier method were employed to identify risk factors and estimate transplant-free survival. Results: A total of 65 PSC patients were enrolled, with male patients accounting for 50.8% and an average age of onset of 44 years. The disease types primarily included large duct PSC (57.9%) and whole duct PSC (22.8%). Most patients (78.5%) sought medical attention due to symptoms, with common clinical manifestations including jaundice (32.3%), fatigue (23.1%), abdominal discomfort (21.5%), pruritus (16.9%), and fever (10.8%). A total of 19 patients (29.2%) had concomitant ulcerative colitis. Compared to large duct PSC or whole duct PSC, small duct PSC showed a lower proportion of concomitant ulcerative colitis (P<0.001) and milder baseline disease severity. After a median follow-up of 29 months (interquartile range: 11,53), 19 patients experienced liver transplantations and/or liver disease-related deaths. The overall 2-year and 5-year transplant-free survival rates for PSC patients were 76.0% and 59.5%, respectively. Elevated bile acid levels were identified as an independent risk factor for poor outcomes in PSC patients. Conclusion: The study population of Chinese PSC patients predominantly consisted of middle-aged males, characterized by a low ratio of asymptomatic cases, a low incidence of associated inflammatory bowel disease, and a low rate of transplant-free survival. Elevated bile acid level was identified as an independent risk factor for poor outcomes in PSC patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
山行未止发布了新的文献求助10
刚刚
刚刚
酷波er的应助被冷傲含海采纳,获得10
1秒前
CCLs发布了新的文献求助10
1秒前
1秒前
1秒前
1秒前
x跳完成签到,获得积分10
2秒前
科研通AI6.2的应助被州府十三采纳,获得10
2秒前
2秒前
123完成签到 ,获得积分10
3秒前
4秒前
Glufo发布了新的文献求助10
5秒前
yang完成签到 ,获得积分10
6秒前
orixero的应助被malone采纳,获得10
6秒前
复杂青筠发布了新的文献求助10
6秒前
sialiangwei发布了新的文献求助10
7秒前
euphydryas完成签到 ,获得积分10
7秒前
rh完成签到,获得积分10
7秒前
桃子发布了新的文献求助10
8秒前
Glufo完成签到,获得积分10
8秒前
天天快乐的应助被小白采纳,获得10
9秒前
Yuki完成签到,获得积分10
9秒前
彭于晏的应助被zgh采纳,获得30
9秒前
zhangzi完成签到,获得积分10
9秒前
菲菲菲非常美丽的毛毛完成签到,获得积分10
9秒前
冰美式冲呀完成签到 ,获得积分10
10秒前
科研大马发布了新的文献求助10
11秒前
12秒前
滚滚咪完成签到,获得积分10
12秒前
Jameszcb完成签到,获得积分10
12秒前
冬夜完成签到 ,获得积分10
13秒前
polywave发布了新的文献求助10
13秒前
徐国发完成签到,获得积分10
14秒前
YuGe完成签到,获得积分10
14秒前
风雪征途完成签到,获得积分10
14秒前
14秒前
记得看文献完成签到,获得积分10
14秒前
naturehome完成签到,获得积分10
15秒前
桃子完成签到,获得积分10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Energie-Contracting 1500
Klimaschutzrecht durch den Energiesektor im Mehrebenensystem – Ein Rechtsvergleich 1000
Oncology Clinical Trials: Successful Design, Conduct, and Analysis, Second Edition 800
Comprehensive Heterocyclic Chemistry IV 400
Qualitative Methodologies in Tourism Studies: Disrupting and Co-creating Critical Research 350
Représentation chimique de la structure des kérogènes et des asphaltènes en fonction de leur origine et de leur degré d'évolution 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8050586
求助须知:如何正确求助?哪些是违规求助? 9479037
关于积分的说明 21296281
捐赠科研通 7618966
什么是DOI,文献DOI怎么找? 3393332
关于科研通互助平台的介绍 2524631
邀请新用户注册赠送积分活动 2431305